Thursday, 4 September 2008

Food, Health Get Top Billing At National Chemistry Meeting

div























Latest News For Nutrition / Diet
Five Ways To Get More Fruit And Veg - World Cancer Research Fund
21 Aug 2008

UNICEF, WFP Deliver Water, Food And Hygiene Kits To Residents Of Conflict-Affected Town In Georgia
21 Aug 2008

School Lunch Participation Increases, While Districts Cut Back On Trans Fats, Sodium And Added Sugar
20 Aug 2008

View more news...

Latest Videos for Nutrition
Choosing a Weight Loss Surgery



Weight red ink surgery bottom provide health benefits to those world Health Organization qualify. How do you know which surgery is right for you? It's important to know the advantages and disadvantages associated with the different types of surgeries...


My Weight-Loss Surgery



Making the decision to have weight-loss surgery is not easy. Listen as an individual tells why she decided to have weight-loss surgery and the ways this decision impacted her life...


View more videos...




Most Popular Categories



cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

















More info

Monday, 25 August 2008

Ninety-Six Week Data On Tibotec Investigational NNRTI, TMC278, Presented At AIDS 2008

�New stage IIb data from Tibotec
Pharmaceuticals Ltd. provides additional information on the safety and
efficaciousness of TMC278, the company's once-daily, investigational
non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV
combination therapy in treatment-naive adults. These findings were
presented today at the International AIDS Conference (AIDS 2008) in Mexico
City.



Seventy-six percent of patients receiving the 25 mg dosage of TMC278,
which is being studied in phase III trials, achieved an undetectable viral
load (


"NNRTIs have been an integral section of combination antiretroviral
therapy for over a decennium," said clinical trial investigator Peter Shalit,
M.D. Swedish Medical Center, Seattle, WA. "The phase IIb information show
potential difference for TMC278 as a once-daily discussion option for patients wHO have
non previously taken anti-HIV medications."



TMC278 is an investigational product, and the safety and efficaciousness of
it, in combination with other antiretroviral agents, has non been
established. Two major phase III trials for TMC278 ar being conducted in
Africa, Asia, Europe, North America and South America, and are currently
recruiting treatment-naive adult patients.

Study Design



The phase IIb dose-finding study (TMC278-C204) evaluated the efficaciousness,
tolerability and safety of once-daily TMC278 at threesome blinded doses (25 mg,
75 mg, and cl mg) and included an open label EFV 600 mg sleeve. A add up of
368 patients were randomised to receive one of the three doses of TMC278 or
EFV, and all patients standard a background regimen of two nucleoside
reverse transcriptase inhibitors (NRTIs), zidovudine + lamivudine (AZT/3TC)
or tenofovir + emtricitabine (TDF/FTC).

Safety Results



Of patients in the TMC278 combined group compared with EFV, 9 per centum
vs. 21 percent experienced rash, 31 percent vs. 48 percentage experienced
flighty system untoward events and 16 per centum vs. 21 percent experienced
psychiatric events.



Overall, patients in the TMC278 combined group (all doses) vs. the EFV
group experienced similar incidences and types of dangerous adverse events
(SAEs) (12 percent vs. 15 pct), grade 3 or 4 adverse events (AEs), (27
percent vs. 21 percentage) and grade 3 or 4 lab abnormalities (26
percent vs. 24 pct).



TMC278 is the third anti-HIV compound to be developed by Tibotec
Pharmaceuticals, which is also developing investigational compounds for the
treatment of hepatitis C and tuberculosis.

About Tibotec Pharmaceuticals Ltd.



Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a
pharmaceutical research and ontogeny company. The Company's main
research and development facilities are in Mechelen, Belgium with offices
in Yardley, PA. Tibotec is dedicated to the discovery and development of
innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet
medical need.


Tibotec Pharmaceuticals Ltd.
http://www.tibotec.com


More info

Friday, 15 August 2008

Gerard Way: 'My Chemical Romance Fans Face Long Wait For New Album'

My Chemical Romance frontman Gerard Way has hinted that fans may stimulate to wait a piece for the band's next album.


Way said the whole group needed clip to rest and �go live� earlier they returned to demonstration songs for the follow-up to 2006's 'The Black Parade'.


In an interview with MTV, Way, who likewise revealed he was planning a top secret project for DC comics, aforementioned the side by side album would be �very different� to its predecessor.


�It's hard to say at this level, but musically, how Black Parade tapped into the glam, classical rock of Queen and Ziggy Stardust, this taps into something different � not tinder, but perhaps in its proto signified,� Way said.


�The esthetical � it is super different, and it is more stripped too. When we receive a chance, we're sledding to mystify together and do some demos and start rolling.�


He said that the stripe were �going to take it slow�, however, adding: �People pauperism to kind of miss us because there was a stop in the last two-and-a-half years where you could have seen us at least erst a month if you wanted."


Way also denied reports that claimed his new material was header in a punk direction.


You can see Gigwise's coverage of the band's Black Parade enlistment below.


My Chemical Romance � The Black Parade


More information

Friday, 27 June 2008

Tyla

Tyla   
Artist: Tyla

   Genre(s): 
Punk: Acid Punk
   



Discography:


Life Or Death?   
 Life Or Death?

   Year: 2002   
Tracks: 15


Passion, Loyalty and Betrayal   
 Passion, Loyalty and Betrayal

   Year:    
Tracks: 15




 






Monday, 23 June 2008

Shirley Bassey Drops Out Of Nelson Mandela Concert

Dame Shirley Bassey has been forced to pull out of the Nelson Mandela concert in London's Hyde Park this Friday (June 27th).



A spokesperson for the singer said that she was “hugely disappointed” because she had been “looking forward to the show immensely”.



Last month, Dame Shirley had to undergo an operation on her stomach in Monaco, where she lives.



As a result of the operation, the singer, famous for her work on James Bond, has been advised by doctors not to travel.



The concert on Friday, which will help raise awareness for the 46664 aids campaign, is scheduled to feature Amy Winehouse, Annie Lenox, Leona Lewis and Razorlight.




See Also

Monday, 16 June 2008

The BBC throws open its music vaults to EMI

Right now, in the smoke-filled boardrooms where corporation bosses make their decisions, a bunch of suits are high-fiving each other while listening to obscure Pink Floyd radio sessions. And the reason is that thousands of hours of unreleased music are soon to be made available, as the BBC throws open its vaults in a new deal with EMI Music.

The agreement between EMI and BBC Worldwide, the Beeb's commercial arm, means that each party will have access to release, broadcast and monetise recordings by EMI artists from the BBC archive. These include unheard sessions by the Beach Boys, Kylie Minogue and David Bowie. Other highlights of the BBC treasure trove include a stripped-down version of Coldplay's Shiver, and live radio sessions by Pink Floyd, recorded around the time of their debut album, Piper at the Gates of Dawn, when Syd Barrett was still a member of the band.












The deal means that EMI will be able to mine the BBC's vaults for recordings by its artists, then release these sessions as DVDs, CDs and digital downloads. The BBC, meanwhile, will be able to use performances from EMI artists in radio, TV and internet programmes.

Both companies will receive royalties from each other's sales, and artists will still have to clear any release project.

"We are very excited about this agreement," said Pete Duckworth, a senior vice president at EMI Music UK. "In the BBC vaults there is a wealth of unreleased and high-quality material from EMI artists that we will now be able to bring to fans. At the same time, we can offer new revenue opportunities to our artists that simply weren't there before."

Universal Music struck a similar bargain with the BBC in 2005.


See Also

Thursday, 5 June 2008

New Orleans 'venue' added to Bonnaroo

A new venue has been added to the forthcoming Bonnaroo Music and Arts Festival, and it�??s all for a good cause.

�??Somethin' Else - New Orleans�?? is a specialty venue developed by promoters, to feature the music of New Orleans and Louisiana, and is modelled after some of the city�??s most famous music clubs such as Preservation Hall, Tipitina's and the Maple Leaf.

To raise money for New Orleans, which suffered immense hurricane damage in recent years, festival-goers will be asked to donate a fee upon entrance to the venue, with all proceeds going directly to support local New Orleans charities.

The venture is also intended to give exposure to New Orleans artists in order to encourage visitors to the city.

The confirmed acts for �??Somethin�?? Else �?? New Orleans�?? are:

Porter - Batiste - Stoltz
Ivan Neville's Dumpstaphunk
Henry Butler and the Game Band
Dirty Dozen Brass Band
Walter 'Wolfman' Washington
Anders Osborne
Big Sam's Funky Nation
Trombone Shorty and Orleans Avenue
Soul Rebels Brass Band
Morning 40 Federation

--By our New York staff.
Find out more about NME.